Skip to content
AdAdvertisement
Value Science Weekly — health economics and market access, in your inbox

Latest News — Page 84

AI in Medical Imaging

Artificial Intelligence And Machine Learning

FDA-Cleared Devices: The Future of AI in Medical Imaging

The integration of AI into medical imaging is reshaping the future of diagnostics and patient care. With FDA-cleared AI devices making enhancements in clinical settings, we’re witnessing a new era of precision and efficiency. From detecting lesions to aiding in diagnosis, AI-enabled CAD devices are enhancing clinician capabilities like never before.

🔍 Dive into our latest article to uncover the insights and innovations behind AI in medical imaging. Learn about the different types of CAD devices and how they’re integrating into clinical workflows to improve patient outcomes.

Let’s embrace the future of healthcare together. #AIinHealthcare #MedicalImaging #InnovationInMedicine #FutureOfHealthcare

Click the link to read more:

Syenza TeamRead ›
Cost of Mental Health Care

Health Equity And Access To Care

The Cost of Mental Health Care: A Cost-Sharing Law

Unveiling the hidden costs of mental health treatment in the US. 📚💰🏥 Discover how cost-sharing impacts access to necessary care and learn about recent policy changes aimed at improving affordability. Learn how cost-sharing laws like the NCS are impacting the cost of mental health care. Read, share and let us know your thoughts! #MentalHealthCare #HealthcareCosts #NCSLaw 📚💰🧠

Syenza TeamRead ›
Cost of HPV Vaccination

Clinical Guidelines And Protocols

Cost of HPV Vaccination: A Global Economic Perspective

Understanding the #CostOfHPVVaccination is crucial in the global fight against cervical cancer. Our latest article offers a comprehensive review of the economic burden of HPV vaccination in low- and middle-income countries. Read it now for key insights on this vital issue. 📚🌍💉 #HealthcareEconomics #CervicalCancerPrevention

Syenza TeamRead ›
Unlocking the Potential of Digital Twins in Healthcare

Artificial Intelligence And Machine Learning

Unlocking the Potential of Digital Twins in Healthcare

Unveiling the transformative potential of #DigitalTwins in healthcare! 🏥 From precision medicine to hospital management, the future looks promising. Read our rapid insights here. #HealthcareInnovation #AI #MachineLearning 🧬🌐

Syenza TeamRead ›
Global Innovation Policies in Healthcare

Clinical Guidelines And Protocols

Opportunities and Challenges in Global Innovation Policies

Discover the impact of current #GlobalInnovationPolicies in healthcare. Learn about the opportunities and risks they present to the biopharmaceutical and healthcare industry. Read our latest article here. #HealthcareInnovation #PandemicPreparedness #Biopharmaceutical 🌍💡🔬

Syenza TeamRead ›
A Closer Look at SGLT2 Inhibitors

Blood Diseases

Cost-effective Treatment: A Closer Look at SGLT2 Inhibitors

Uncover the potential of SGLT2 inhibitors in managing diabetes and associated conditions. 📚💡🔬Our latest article delves into their cost-effectiveness and future prospects. Read now to stay informed! #DiabetesTreatment #HealthcareInnovation #SGLT2Inhibitors 💊🔬

Syenza TeamRead ›
Machine Learning in Long QT Syndrome Diagnosis

Artificial Intelligence And Machine Learning

Machine Learning to Improve Diagnosis of Long QT Syndrome

Explore how #MachineLearning can revolutionise the diagnosis of Long QT Syndrome. Recent research shows that CNNs can accurately identify this cardiac condition, even in patients with concealed symptoms. Find out more in our latest article. #HealthcareInnovation #AIinHealthcare 🩺🧬🤖

Syenza TeamRead ›
Correct Antibiotic Use

Clinical Guidelines And Protocols

Cost-saving Implications of Correct Antibiotic Use

Discover the cost-saving power of correct antibiotic use! 🌍💊 Recent updates from #WHO and #NICE highlight the importance of targeted antibiotic use in combatting #AntibioticResistance. Join the conversation and learn more here. #Healthcare #LifeSciences

Syenza TeamRead ›
Preventing Cardiovascular Disease

Cardiovascular And Metabolic Diseases

Preventing Cardiovascular Disease: The Financial Implications

Understanding the cost implications of #statins in managing #CardiovascularDisease is crucial for effective healthcare policy. Our latest article explores the need for optimal pricing policies for statins and their impact on healthcare costs. Learn more here📚💡 #HealthcareResearch #PreventingCardiovascularDisease

Syenza TeamRead ›
Anifrolumab in systemic lupus erythematosus management

Biologics And Biosimilars

Anifrolumab in Systemic Lupus Erythematosus Management

Discover the role of #Anifrolumab in managing systemic lupus erythematosus (SLE). This breakthrough treatment not only enhances patients’ quality of life but also reduces healthcare costs. Read our latest article to learn more. #SLE #HealthcareInnovation #Cost-Effectiveness 📚🔬💊👩‍⚕️👨‍⚕️

Syenza TeamRead ›
Artificial Intelligence in Predicting Cardiac Amyloidosis

Artificial Intelligence And Machine Learning

Artificial Intelligence in Predicting Cardiac Amyloidosis in TAVR

Discover how #AI is transforming the prediction of Cardiac Amyloidosis in aortic stenosis patients undergoing TAVR. Read our latest article to learn more about this breakthrough. #ArtificialIntelligence #HealthcareInnovation 🧠💡👩‍⚕️👨‍⚕️

Syenza TeamRead ›
Economic Burden of End-Stage Renal Disease

Cardiovascular And Metabolic Diseases

The Economic Burden of End-Stage Renal Disease in Sudan

Uncover the economic implications of End-Stage Renal Disease (ESRD) in Sub-Saharan Africa, with a focus on Sudan. Learn how the disease affects patients, caregivers, and the wider society. Read more here: #ESRD #HealthEconomics #KidneyDisease 🌍💰🏥

Syenza TeamRead ›
Thiopurine Therapy and Pharmacogenetic testing

Blood Diseases

The Crucial Role of Pharmacogenetic testing in Thiopurine Therapy

🔬 Discover the crucial role of #TPMT and #NUDT15 in #ThiopurineTherapy in our latest article. Understand why genetic testing is essential to optimise treatment, reduce risk, and save costs. Read now ➡️ #Pharmacogenetics #CostEffectiveness #PharmaMarketAccess

Syenza TeamRead ›
Colonoscopy Screening for Ulcerative Colitis

Artificial Intelligence And Machine Learning

Colonoscopy Screening for Ulcerative Colitis: Cost-Effectiveness

Looking for insights on the cost-effectiveness of annual colonoscopy screening for Ulcerative Colitis patients? Check out our latest article. We delve into the Saudi scenario, the potential of AI intervention, and much more. #UlcerativeColitis #ColonoscopyScreening #HealthcareResearch 👉

Syenza TeamRead ›
Precision Medicine in Healthcare

Biologics And Biosimilars

Precision Medicine: A New Paradigm in Healthcare

🔬 Precision Medicine is paving the way for personalised treatments and improved health outcomes. 💡 Discover how a public-private joint venture in Australia is addressing the challenges posed by this new paradigm in our latest article and how precision medicine could reduce cost in cancer clinical trials. #PrecisionMedicine #HealthcareInnovation #Oncology #CostEffectiveness👉

Syenza TeamRead ›
The ‘black box’ Phenomenon in Artificial Intelligence

Artificial Intelligence And Machine Learning

The ‘black box’ Phenomenon in Artificial Intelligence

🚀 Interesting breakthrough at the University of Illinois Urbana-Champaign’s Beckman Institute for Advanced Science and Technology! Researchers tackle the ‘black box’ problem in healthcare AI, enhancing transparency and trust. #AI #Healthcare #Innovation 🧠🤖 Let’s reimagine AI interpretation for a more informed future!

Syenza TeamRead ›